NRG-HN016: The "CONCISE" Study for Locoregionally Advanced Head and Neck Cancer Patients that are Unable to Take Cisplatin
Our co-hosts interview the PI of the active NRG-HN016 (CONCISE) trial, Dr. Loren Mell. The CONCISE study is a randomized phase III trial comparing radiation therapy (RT) plus carboplatin/paclitaxel vs...
13 Aug 17min
NRG-GU015, the "ARCHER" Study for Muscle Invasive Bladder Cancer
Our co-hosts welcome Dr. Scott Delacroix and Dr. Himanshu Nagar to discuss bladder cancer, bladder preservation, and the newly activated NRG-GU015 (ARCHER) clinical trial. In this episode, the experts...
30 Jul 28min
NRG2026 and Glioblastoma Awareness Day Special
For Glioblastoma Awareness Day we discuss the NRG-CC017 study of TMPRT + Temozolomide for glioblastoma with PI, Dr. Huang. We also discuss the challenges faced by larger institutions with Dr. Abraham.
15 Jul 38min
Uterine Cancer Awareness Month 2026
This special Uterine Cancer Month episode includes three different perspectives in Uterine Cancer research. First we interview uterine and ovarian cancer survivor, NRG PAC Member, and Uterine Corpus S...
23 Jun 49min
Prostate Cancer Analysis and Translational Science from ASCO 2026
In this episode, we discuss the results of the combined analysis of the prostate cancer studies RTOG 9202, 9413, 9902, and 0521 as well as learn more about translational science at NRG.
30 Mai 29min
NRG-GY018 Mature Results from ASCO 2026
Our Podcast Co-Hosts interview NRG-GY018 study PI, Dr. Ramez Eskander on the reported mature results of the study in advanced or recurrent endometrial cancer at ASCO 2026.
29 Mai 18min
Special Episode with ASTRO’s CEO for ASTRO Advocacy Day
The NRG Oncology Podcast discusses the American Society for Radiation Oncology’s (ASTRO) vision and goals, collaborations with cooperative groups such as NRG Oncology, and overcoming obstacles in radi...
27 Apr 31min
NRG-GY019 Plenary Presentation at SGO 2026
Our co-hosts interview Dr. Amanda Nickles Fader on the recently present results of NRG-GY019.
10 Apr 17min
